The COVID-19 Pandemic Converges With Kidney Policy Transformation: Implications for CKD Population Health.
作者信息
Tummalapalli Sri Lekha, Warnock Neil, Mendu Mallika L
机构信息
Division of Healthcare Delivery Science & Innovation, Department of Population Health Sciences, Weill Cornell Medicine.
Medical Affairs - Market Access, Bayer AG, Whippany, NJ.
出版信息
Am J Kidney Dis. 2021 Feb;77(2):268-271. doi: 10.1053/j.ajkd.2020.10.004. Epub 2020 Nov 7.
Abstract
摘要
相似文献
1
The COVID-19 Pandemic Converges With Kidney Policy Transformation: Implications for CKD Population Health.
Am J Kidney Dis. 2021 Feb;77(2):268-271. doi: 10.1053/j.ajkd.2020.10.004. Epub 2020 Nov 7.
2
The Impact of COVID-19 on Racial-Ethnic Health Disparities in the US: Now Is the Time To Address the Problem.
J Natl Med Assoc. 2021 Apr;113(2):195-198. doi: 10.1016/j.jnma.2020.08.008. Epub 2020 Sep 8.
3
Racial and Ethnic Disparities in Excess Deaths Among Persons With Kidney Failure During the COVID-19 Pandemic, March-July 2020.
Am J Kidney Dis. 2021 May;77(5):827-829. doi: 10.1053/j.ajkd.2021.02.003. Epub 2021 Feb 11.
4
Racial and ethnic disparities in adult COVID-19 and the future impact on child health.
Pediatr Res. 2021 Apr;89(5):1052-1054. doi: 10.1038/s41390-021-01377-x. Epub 2021 Feb 9.
5
Sustainable social development: tackling poverty to achieve kidney health equity.
Nat Rev Nephrol. 2021 Jan;17(1):3-4. doi: 10.1038/s41581-020-00342-x.
6
Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic.
PLoS Med. 2021 Apr 22;18(4):e1003604. doi: 10.1371/journal.pmed.1003604. eCollection 2021 Apr.
7
Equitable Access to Liver Transplant: Bridging the Gaps in the Social Determinants of Health.
Hepatology. 2021 Nov;74(5):2808-2812. doi: 10.1002/hep.31986. Epub 2021 Jul 13.
8
Social Determinants of Health and Implementation Research: Lessons from the COVID-19 Pandemic.
Ethn Dis. 2021 Jan 21;31(1):5-8. doi: 10.18865/ed.31.1.5. eCollection 2021 Winter.
9
Incidence and Outcomes of COVID-19 in People With CKD: A Systematic Review and Meta-analysis.
Am J Kidney Dis. 2021 Dec;78(6):804-815. doi: 10.1053/j.ajkd.2021.07.003. Epub 2021 Aug 5.
10
Alternative Payment Models and Opportunities to Address Disparities in Kidney Disease.
Am J Kidney Dis. 2021 May;77(5):769-772. doi: 10.1053/j.ajkd.2020.09.008. Epub 2020 Oct 21.
引用本文的文献
1
Kidney failure-related excess mortality during the first three years of the COVID-19 pandemic in the United States: a nation-wide, population-based analysis.
BMC Public Health. 2025 Jan 17;25(1):210. doi: 10.1186/s12889-025-21422-2.
2
Nephrologist Performance in the Merit-Based Incentive Payment System.
Kidney Med. 2021 Jul 21;3(5):816-826.e1. doi: 10.1016/j.xkme.2021.06.006. eCollection 2021 Sep-Oct.
3
Evaluation of Racial, Ethnic, and Socioeconomic Disparities in Initiation of Kidney Failure Treatment During the First 4 Months of the COVID-19 Pandemic.
JAMA Netw Open. 2021 Oct 1;4(10):e2127369. doi: 10.1001/jamanetworkopen.2021.27369.
本文引用的文献
1
Technology, Telehealth, and Nephrology: The Time Is Now.
Kidney360. 2020 Jun 3;1(8):834-836. doi: 10.34067/KID.0002382020. eCollection 2020 Aug 27.
2
COVID-19 and Kidney Disease Disparities in the United States.
Adv Chronic Kidney Dis. 2020 Sep;27(5):427-433. doi: 10.1053/j.ackd.2020.06.005. Epub 2020 Jun 23.
3
Telehealth for Home Dialysis in COVID-19 and Beyond: A Perspective From the American Society of Nephrology COVID-19 Home Dialysis Subcommittee.
Am J Kidney Dis. 2021 Jan;77(1):142-148. doi: 10.1053/j.ajkd.2020.09.005. Epub 2020 Sep 28.
4
Early Delays in Insurance Coverage and Long-term Use of Home-based Peritoneal Dialysis.
Med Care. 2020 Jul;58(7):632-642. doi: 10.1097/MLR.0000000000001350.
5
Hospitalization and Mortality among Black Patients and White Patients with Covid-19.
N Engl J Med. 2020 Jun 25;382(26):2534-2543. doi: 10.1056/NEJMsa2011686. Epub 2020 May 27.
6
Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
BMJ. 2020 May 22;369:m1966. doi: 10.1136/bmj.m1966.
7
Measuring Quality in Kidney Care: An Evaluation of Existing Quality Metrics and Approach to Facilitating Improvements in Care Delivery.
J Am Soc Nephrol. 2020 Mar;31(3):602-614. doi: 10.1681/ASN.2019090869. Epub 2020 Feb 13.
8
Development of an electronic health record-based chronic kidney disease registry to promote population health management.
BMC Nephrol. 2019 Mar 1;20(1):72. doi: 10.1186/s12882-019-1260-y.
9
Addressing Financial Disincentives to Improve CKD Care.
J Am Soc Nephrol. 2018 Nov;29(11):2610-2612. doi: 10.1681/ASN.2018040438. Epub 2018 Oct 10.
10
US Physician Practices Spend More Than $15.4 Billion Annually To Report Quality Measures.
Health Aff (Millwood). 2016 Mar;35(3):401-6. doi: 10.1377/hlthaff.2015.1258.
Zotero 插件